SLNO SG&A Expense Growth
Soleno Therapeutics Inc · SG&A Expense Growth
SLNO SG&A Expense Growth
Latest reported24.81%period ending
SLNO FY SG&A Growth (YoY) (0.00% → 24.81%)
Latest values, visible window
High-resolution chart · PNG
SLNO sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 24.8127% | |
| 685.2607% | |
| 36.9464% | |
| -8.9025% | |
| 64.6252% | |
| 41.6793% | |
| -29.3319% | |
| -0.8227% | |
| -20.9927% | |
| 6.2006% | |
| 170.0345% | |
| 98.8828% | |
| 30.142% | |
| 0% |